Group 1 - The total financing scale in the PE/VC sector decreased to 5.791 billion RMB from over 10 billion RMB in the previous week, with NIO Energy completing a strategic financing of 2.5 billion RMB [1][3][34] - The advanced manufacturing sector attracted over 1.01 billion RMB through 6 financing deals, while the semiconductor sector raised over 360 million RMB through 5 financing deals [5][6] - The most active regions for financing were Zhejiang Province, Beijing, and Guangdong Province, with 7, 6, and 5 deals respectively [7][9] Group 2 - NIO Energy, established in 2017, focuses on providing charging and battery swap services and aims to offer efficient energy solutions for B-end customers [35] - Guangdong Dongqin Technology completed a strategic financing of 720 million RMB, which will help enhance market competitiveness and accelerate development [29] - Electric Butler Group completed over 100 million RMB in C round financing to support rapid growth in the power service sector [18] Group 3 - The healthcare sector saw significant activity, with Shenzhen Fowo Pharmaceutical completing a 100 million RMB B+ round financing led by Wuhan Optics Valley [16] - Starry Technology completed nearly 100 million RMB in angel financing to advance its iPSC regenerative medicine platform [12] - OneLink Technology secured seed round financing to accelerate the production and clinical research of its second-generation suspension system [13] Group 4 - The semiconductor sector is gaining traction, with companies like Chen Zhi Semiconductor completing A round financing, focusing on high-performance automotive-grade chips [21][22] - RockFlow, a financial technology company, raised 10 million USD in A round financing to enhance its AI capabilities for young investors [39] - Deep Principle, an AI for Chemistry/Materials company, completed a significant Pre-A round financing to accelerate its technology platform's industrialization [40]

合作伙伴征集：2025全球手术机器人大会 报名：首届全球眼科大会 | 暂定议程 报名：首届全球心血管大会 | 奖项报名倒计时 报名：首届全球骨科大会 | 奖项报名倒计时 近日， 合肥易联立通医疗科技有限公司 （以下简称"易联立通"）宣布完成种子轮融资。本轮融资由 合肥产 投国正投资与合肥包河创投 联合投资，旭医资本担任长期财务顾问， 融资金额未公开披露 。此次融资将用于 加速公司核心产品 "鲲鹏"二代悬吊系统 的量产验证、临床研究及三代产品的研发升级。 # 关于 易联立通 易联立通 成立于2024年7月16日，总部位于安徽省合肥市包河区。公司专注于 泌尿外科 领域，致力于 良性 前列腺增生（BPH）智能设备和高值创新微创耗材的研发、生产与销售 。 产品与技术介绍 易联立通的核心产品 "鲲鹏"二代悬吊系统 是 全球第二款、国产首款 解决大范围腺体体积束缚有效性的悬吊 系统，其技术特点和优势如下： "鲲鹏"二代悬吊系统目前已进入样机量产阶段， 计划于2027年上市 。同时，公司正在加速研发第三代升级 产品，预计 2025年秋季推出样机 。 技术领先 ：采用创新分体式结构， 突破了大范围腺体体积束缚有效性的技术瓶颈 ...